The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said Friday. Prasad was appointed last year as director of the FDA’s Center for Biologics Evaluation and Research, a position with heavy influence over the regulation of vaccines and other medical products. But his tenure has been dogged by controversy. Prasad briefly stepped down in July, after less than three months on the job, following disputes over the FDA’s decision to pause shipments of a gene therapy for Duchenne muscular dystrophy, a neuromuscular disorder. The de

The Food and Drug Administration’s vaccine chief, Dr. Vinay Prasad, will depart the agency next month, an FDA spokesperson said Friday. Prasad was appointed last year as director of the FDA’s Center for Biologics Evaluation and Research, a position with heavy influence over the regulation of vaccines and other medical products. But his tenure has been dogged by controversy. Prasad briefly stepped down in July, after less than three months on the job, following disputes over the FDA’s decision to pause shipments of a gene therapy for Duchenne muscular dystrophy, a neuromuscular disorder. The de